Status:
COMPLETED
IL-8+ naïve T Cells as a Biomarker for Thymoma Identification
Lead Sponsor:
Shanghai Zhongshan Hospital
Conditions:
Thymoma
Eligibility:
All Genders
18+ years
Brief Summary
According to the existing literature reports, the misdiagnosis rate of CT is as high as 22% - 68%. Thymic cyst and lymphoma are usually misdiagnosed as thymoma, resulting in many unnecessary operation...
Detailed Description
This study is a prospective, multicenter diagnostic accuracy study. 310 patients with anterior mediastinal space occupying lesions who meet the enrollment conditions are planned to be recruited contin...
Eligibility Criteria
Inclusion
- Adult, aged 18 and above；
- Patients with anterior mediastinal mass on imaging (chest CT or MRI)；
- The patient's anterior mediastinal mass can be diagnosed by biopsy or surgery.
Exclusion
- Adolescents and children under the age of 18;
- The patient's anterior mediastinal mass can not be diagnosed by biopsy or surgery.
Key Trial Info
Start Date :
May 2 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2024
Estimated Enrollment :
310 Patients enrolled
Trial Details
Trial ID
NCT05255965
Start Date
May 2 2023
End Date
October 31 2024
Last Update
January 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
180 Fenglin Road
Shanghai, China, 200032